Latest by Camille Arkell
What we know about PrEP use during pregnancy and when breastfeeding, and its use by trans women, trans men, and people who inject drugs.
An examination of what we know about the risk of passing HIV through pregnancy, childbirth, and infant feeding.
Brief IAS 2017 summaries of ongoing research on pre-exposure prophylaxis (PrEP), evaluating its long-term effectiveness and safety, patient experiences, and alternative dosing schedules, such as an on-demand regimen.
A review of evidence on a range of effective interventions to reduce the risk of HIV transmission among people who inject drugs.
A meta-analysis of five randomized controlled trials that included women shows that, with good adherence, oral PrEP is effective at reducing the risk for HIV transmission in women.
What is the evidence on rinsing needles and syringes with bleach to prevent HIV and hepatitis C transmission among people who inject drugs?
Camille Arkell discusses the female genital tract's unique biological vulnerabilities to HIV, its protective defences against HIV and HIV prevention approaches available to women.
How well does daily oral PrEP work? Does intermittent PrEP work? Does oral PrEP work as well for women as for men? CATIE answers these questions and more.